Close Menu
  • News
  • Medical
  • Technology
  • Nanomaterials
  • Research
  • Blog
    • Nasiol.com
  • Contact
    • Tech7685@gmail.com
What's Hot

Unique molecule may lead to smaller, more efficient computers

May 9, 2025

Depositing quantum dots on corrugated chips improves photodetector capabilities

May 8, 2025

Ultrasonic nanocrystal surface modification restores stainless steel’s corrosion resistance

May 7, 2025
Facebook X (Twitter) Instagram
Nanotech – Nanomaterials | Medical | Research | News Stories Updated Daily Nanotech – Nanomaterials | Medical | Research | News Stories Updated Daily
  • News
  • Medical
  • Technology
  • Nanomaterials
  • Research
  • Blog
    • Nasiol.com
  • Contact
    • Tech7685@gmail.com
Facebook X (Twitter) Instagram
Nanotech – Nanomaterials | Medical | Research | News Stories Updated Daily Nanotech – Nanomaterials | Medical | Research | News Stories Updated Daily
Home»Research»Revolutionizing Cancer Treatment with Johns Hopkins’ Latest Immunotherapy Breakthrough
Research

Revolutionizing Cancer Treatment with Johns Hopkins’ Latest Immunotherapy Breakthrough

December 20, 2023No Comments3 Mins Read
Facebook Twitter Pinterest Telegram LinkedIn Tumblr WhatsApp Email
Revolutionizing Cancer Treatment with Johns Hopkins’ Latest Immunotherapy Breakthrough
Share
Facebook Twitter LinkedIn Pinterest Telegram Email

Cancer, a disease that affects millions globally, presents a multifaceted challenge in the medical field. Its ability to adapt and resist various treatments has continually prompted scientists to seek innovative solutions. A significant development in this field comes from the research team at Johns Hopkins University, offering a novel approach to cancer immunotherapy.

Traditional treatments, while effective in many cases, often fall short due to cancer’s complex nature and its ability to evade the immune system. This is where the groundbreaking work of Hai-Quan Mao, director of Johns Hopkins’ Institute for NanoBioTechnology, and his team becomes crucial.

Hai-Quan Mao highlighted the essence of their discovery “This research marks a pivotal turning point in our understanding of how lipid nanoparticles can be harnessed to optimise anticancer immunity. Our findings unlock new avenues for enhancing the efficacy of RNA-based treatments for cancer and infectious diseases.”

The team’s innovation revolves around using lipid nanoparticles—tiny structures made of fat—to dramatically increase the potency of therapeutic cancer vaccines. These vaccines train the immune system to identify and attack cancer cells. The introduction of lipid nanoparticles has revolutionised this approach.

Lipid nanoparticles have previously gained attention for their role in mRNA COVID-19 vaccine delivery. Building on this success, Mao’s team, including Yining Zhu, a biomedical engineering PhD candidate, and Sean C. Murphy, a professor of pathology at the University of Washington, focused on enhancing these particles for cancer treatment. By fine-tuning the composition of the nanoparticles, the researchers achieved a dual activation of the immune system, harnessing both Th1 and Th2 cell responses. This dual activation is significant because it allows for a more coordinated and robust attack on cancer cells.

See also  Pharmacy researchers develop nanoparticle treatment for skin and lung fibrosis

Furthermore, the research team combined these enhanced lipid nanoparticles with checkpoint inhibitor treatments. These are drugs used in immunotherapy to help the immune system recognise and combat cancer cells more effectively. By integrating lipid nanoparticles into this treatment, the team found an increased potential to reduce tumour sizes and extend patient survival times.

Despite these advancements, challenges remain. The human body’s complex immune responses and the varied nature of cancer mean that individual patient reactions can differ widely. Integrating new treatments into established medical protocols requires careful consideration and further research.

In the biotech sector, companies like Moderna and BioNTech, which have already utilised lipid nanoparticles in vaccine delivery, may see new avenues for expansion in cancer treatment. These firms could leverage their experience with lipid nanoparticles to explore enhanced cancer therapies.

Specifically, Moderna’s success with the SM-102 ionisable lipid in their COVID-19 vaccine demonstrates their capability in effective mRNA delivery, which could be pivotal in developing similar technologies for cancer therapeutics.

Furthermore, the proficiency of these companies in nanoparticle-based delivery systems can accelerate the development of more targeted and efficient cancer treatments, potentially leading to better patient outcomes.

Conclusion

The potential for lipid nanoparticles in cancer therapy is vast and promising. As research in this area continues to evolve, it could lead to more personalised and effective treatments, offering new hope in the ongoing fight against cancer. This development represents a significant step forward in cancer therapy and exemplifies the continuous evolution of medical science in combating one of the most challenging diseases of our time.

See also  Tiny vibrating bubbles could lead to better water treatment

COMPANIES TO WATCH:

Nanobiotix, Genedit, Aera

Author:

Kate Sivess-Symes

Content Producer and Writer

Nano Magazine | The Breakthrough 

Image

Source link

Breakthrough cancer Hopkins immunotherapy Johns Latest Revolutionizing Treatment
Share. Facebook Twitter Pinterest LinkedIn Tumblr Email

Related Posts

Nanoparticle treatment combined with radiation therapy significantly improves glioblastoma survival in mice

May 3, 2025

In What Ways Can Nanosensors Be Used to Detect Cancer?

April 22, 2025

Ultra-thin, flexible silicone nanosensor could have huge impact on brain injury treatment

April 22, 2025

AI combined with nanotech can detect oral cancer earlier

April 21, 2025

Engineers develop a way to mass manufacture nanoparticles that deliver cancer drugs directly to tumors

April 15, 2025

Magnetic nanoparticles transport drugs deep into tumors to slow cancer growth

March 27, 2025

Comments are closed.

Top Articles
News

Upgraded atomic force microscope captures 3D images of calcite dissolving

News

Hummingbird beak points the way to future micro machine design

News

Cutting-Edge Quantum Sensor Unveils the Hidden Atomic World

Editors Picks

Unique molecule may lead to smaller, more efficient computers

May 9, 2025

Depositing quantum dots on corrugated chips improves photodetector capabilities

May 8, 2025

Ultrasonic nanocrystal surface modification restores stainless steel’s corrosion resistance

May 7, 2025

Structure dictates effectiveness and safety in nanomedicine, driving therapeutic innovation, say scientists

May 7, 2025
About Us
About Us

Your go-to source for the latest nanotechnology breakthroughs. Explore innovations, applications, and implications shaping the future at the molecular level. Stay informed, embrace the nano-revolution.

We're accepting new partnerships right now.

Facebook X (Twitter) Instagram Pinterest
Our Picks

Ballistic transport in long molecular wires: Porphyrin nanoribbons

March 12, 2024

Novel framework promotes efficient electromagnetic wave absorption

October 17, 2023

Scientists discover nanofabrication of photonic crystals on buried ancient Roman glass

September 23, 2023

Subscribe to Updates

Get the latest creative Nano Tech news from Elnano.com

© 2025 Elnano.com - All rights reserved.
  • Contact
  • Privacy Policy
  • Terms & Conditions

Type above and press Enter to search. Press Esc to cancel.

Cleantalk Pixel